Dutch national guidelines for locally recurrent rectal cancer

Floor Piqeur, Davy M.J. Creemers, Evi Banken, Liën Coolen, Pieter J. Tanis, Monique Maas, Mark Roef, Corrie A.M. Marijnen, Irene E.G. van Hellemond, Joost Nederend, Harm J.T. Rutten, Heike M.U. Peulen, Jacobus W.A. Burger*

*Corresponding author for this work

Research output: Contribution to journalReview articlePopular


Due to improvements in treatment for primary rectal cancer, the incidence of LRRC has decreased. However, 6–12% of patients will still develop a local recurrence. Treatment of patients with LRRC can be challenging, because of complex and heterogeneous disease presentation and scarce − often low-grade − data steering clinical decisions. Previous consensus guidelines have provided some direction regarding diagnosis and treatment, but no comprehensive guidelines encompassing all aspects of the clinical management of patients with LRRC are available to date. The treatment of LRRC requires a multidisciplinary approach and overarching expertise in all domains. This broad expertise is often limited to specific expert centres, with dedicated multidisciplinary teams treating LRRC. A comprehensive, narrative literature review was performed and used to develop the Dutch National Guideline for management of LRRC, in an attempt to guide decision making for clinicians, regarding the complete clinical pathway from diagnosis to surgery.

Original languageEnglish
Article number102736
JournalCancer Treatment Reviews
Publication statusPublished - Jun 2024

Bibliographical note

Publisher Copyright:
© 2024


Dive into the research topics of 'Dutch national guidelines for locally recurrent rectal cancer'. Together they form a unique fingerprint.

Cite this